Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211

Jessica Justman; Timothy Skalland; Ayana Moore; Christopher I. Amos; Mark A. Marzinke; Sahar Z. Zangeneh; Colleen F. Kelley; Rebecca Singer; Stockton Mayer; Yael Hirsch-Moverman; Susanne Doblecki-Lewis; David Metzger; Elizabeth Barranco; Ken Ho; Ernesto T.A. Marques; Margaret Powers-Fletcher; Patricia J. Kissinger; Jason E. Farley; Carrie Knowlton; Magdalena E. Sobieszczyk; Shobha Swaminathan; Domonique Reed; Jean De Dieu Tapsoba; Lynda Emel; Ian Bell; Krista Yuhas; Leah Schrumpf; Laura Mkumba; Jontraye Davis; Jonathan Lucas; Estelle Piwowar-Manning; Shahnaz Ahmed

doi:10.3201/eid3002.230863

Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021¹

Jessica Justman, Timothy Skalland, Ayana Moore, Christopher I. Amos, Mark A. Marzinke, Sahar Z. Zangeneh, Colleen F. Kelley, Rebecca Singer, Stockton Mayer, Yael Hirsch-Moverman, Susanne Doblecki-Lewis, David Metzger, Elizabeth Barranco, Ken Ho, Ernesto T.A. Marques, Margaret Powers-Fletcher, Patricia J. Kissinger, Jason E. Farley, Carrie Knowlton, Magdalena E. SobieszczykShobha Swaminathan, Domonique Reed, Jean De Dieu Tapsoba, Lynda Emel, Ian Bell, Krista Yuhas, Leah Schrumpf, Laura Mkumba, Jontraye Davis, Jonathan Lucas, Estelle Piwowar-Manning, Shahnaz Ahmed

Research output: Contribution to journal › Article › peer-review

Abstract

During January–August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.

Original language	English (US)
Pages (from-to)	245-254
Number of pages	10
Journal	Emerging infectious diseases
Volume	30
Issue number	2
DOIs	https://doi.org/10.3201/eid3002.230863
State	Published - Feb 2024

ASJC Scopus subject areas

Epidemiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.3201/eid3002.230863

Cite this

Justman, J., Skalland, T., Moore, A., Amos, C. I., Marzinke, M. A., Zangeneh, S. Z., Kelley, C. F., Singer, R., Mayer, S., Hirsch-Moverman, Y., Doblecki-Lewis, S., Metzger, D., Barranco, E., Ho, K., Marques, E. T. A., Powers-Fletcher, M., Kissinger, P. J., Farley, J. E., Knowlton, C., ... Ahmed, S. (2024). Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021¹. Emerging infectious diseases, 30(2), 245-254. https://doi.org/10.3201/eid3002.230863

Justman, J, Skalland, T, Moore, A, Amos, CI, Marzinke, MA, Zangeneh, SZ, Kelley, CF, Singer, R, Mayer, S, Hirsch-Moverman, Y, Doblecki-Lewis, S, Metzger, D, Barranco, E, Ho, K, Marques, ETA, Powers-Fletcher, M, Kissinger, PJ, Farley, JE, Knowlton, C, Sobieszczyk, ME, Swaminathan, S, Reed, D, Tapsoba, JDD, Emel, L, Bell, I, Yuhas, K, Schrumpf, L, Mkumba, L, Davis, J, Lucas, J, Piwowar-Manning, E & Ahmed, S 2024, 'Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021¹', Emerging infectious diseases, vol. 30, no. 2, pp. 245-254. https://doi.org/10.3201/eid3002.230863

@article{d30733b465aa4c9a8a20e929bf1caeb3,

title = "Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211",

abstract = "During January–August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.",

author = "Jessica Justman and Timothy Skalland and Ayana Moore and Amos, {Christopher I.} and Marzinke, {Mark A.} and Zangeneh, {Sahar Z.} and Kelley, {Colleen F.} and Rebecca Singer and Stockton Mayer and Yael Hirsch-Moverman and Susanne Doblecki-Lewis and David Metzger and Elizabeth Barranco and Ken Ho and Marques, {Ernesto T.A.} and Margaret Powers-Fletcher and Kissinger, {Patricia J.} and Farley, {Jason E.} and Carrie Knowlton and Sobieszczyk, {Magdalena E.} and Shobha Swaminathan and Domonique Reed and Tapsoba, {Jean De Dieu} and Lynda Emel and Ian Bell and Krista Yuhas and Leah Schrumpf and Laura Mkumba and Jontraye Davis and Jonathan Lucas and Estelle Piwowar-Manning and Shahnaz Ahmed",

year = "2024",

month = feb,

doi = "10.3201/eid3002.230863",

language = "English (US)",

volume = "30",

pages = "245--254",

journal = "Emerging infectious diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "2",

}

TY - JOUR

T1 - Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211

AU - Justman, Jessica

AU - Skalland, Timothy

AU - Moore, Ayana

AU - Amos, Christopher I.

AU - Marzinke, Mark A.

AU - Zangeneh, Sahar Z.

AU - Kelley, Colleen F.

AU - Singer, Rebecca

AU - Mayer, Stockton

AU - Hirsch-Moverman, Yael

AU - Doblecki-Lewis, Susanne

AU - Metzger, David

AU - Barranco, Elizabeth

AU - Ho, Ken

AU - Marques, Ernesto T.A.

AU - Powers-Fletcher, Margaret

AU - Kissinger, Patricia J.

AU - Farley, Jason E.

AU - Knowlton, Carrie

AU - Sobieszczyk, Magdalena E.

AU - Swaminathan, Shobha

AU - Reed, Domonique

AU - Tapsoba, Jean De Dieu

AU - Emel, Lynda

AU - Bell, Ian

AU - Yuhas, Krista

AU - Schrumpf, Leah

AU - Mkumba, Laura

AU - Davis, Jontraye

AU - Lucas, Jonathan

AU - Piwowar-Manning, Estelle

AU - Ahmed, Shahnaz

PY - 2024/2

Y1 - 2024/2

N2 - During January–August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.

AB - During January–August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.

UR - http://www.scopus.com/inward/record.url?scp=85183577271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85183577271&partnerID=8YFLogxK

U2 - 10.3201/eid3002.230863

DO - 10.3201/eid3002.230863

M3 - Article

C2 - 38270128

AN - SCOPUS:85183577271

SN - 1080-6040

VL - 30

SP - 245

EP - 254

JO - Emerging infectious diseases

JF - Emerging infectious diseases

IS - 2

ER -

Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021¹

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this